Abstract
Background
There is an urgent need for epidemiological research in primary care to develop risk assessment processes for patients presenting with COVID-19, but lack of a standardised approach to data collection is a significant barrier to implementation.
Aim
To collate a list of relevant symptoms, assessment items, demographics, and lifestyle and health conditions associated with COVID-19, and match these data items with corresponding SNOMED CT clinical terms to support the development and implementation of consultation templates.
Design & setting
Published and preprint literature for systematic reviews, meta-analyses, and clinical guidelines describing the symptoms, assessment items, demographics, and/or lifestyle and health conditions associated with COVID-19 and its complications were reviewed. Corresponding clinical concepts from SNOMED CT, a widely used structured clinical vocabulary for electronic primary care health records, were identified.
Method
Guidelines and published and unpublished reviews (N = 61) were utilised to collate a list of relevant data items for COVID-19 consultations. The NHS Digital SNOMED CT Browser was used to identify concept and descriptive identifiers. Key implementation challenges were conceptualised through a Normalisation Process Theory (NPT) lens.
Results
In total, 32 symptoms, eight demographic and lifestyle features, 25 health conditions, and 20 assessment items relevant to COVID-19 were identified, with proposed corresponding SNOMED CT concepts. These data items can be adapted into a consultation template for COVID-19. Key implementation challenges include: 1) engaging with key stakeholders to achieve ’buy in’; and 2) ensuring any template is usable within practice settings.
Conclusion
Consultation templates for COVID-19 are needed to standardise data collection, facilitate research and learning, and potentially improve quality of care for COVID-19.
How this fits in
Recording of clinical features of COVID-19 presentation in primary care is likely to be poor in the absence of a template. A rapid literature review was therefore conducted to collate a comprehensive list of symptoms, assessment items, demographics, and lifestyle and health conditions associated with COVID-19, with proposed corresponding SNOMED CT clinical terms. The evidence base around COVID-19 is rapidly evolving and this list may have to be updated in the future as new evidence becomes available. These data items can be adapted into a consultation template to standardise data collection, which in turn can facilitate research and improve quality of record keeping. In practice, there are often multiple SNOMED CT clinical terms for recording a single data item. A professional consensus will be needed among clinician users to agree on appropriate SNOMED CT clinical terms to be used in a template. Implementation and widespread use of a COVID-19 consultation template will need positive engagement with key stakeholders.
Introduction
The COVID-19 pandemic is an unprecedented global health challenge. Understanding of the epidemiology and clinical features of COVID-19 is rapidly evolving. New evidence is constantly emerging, with articles being published or uploaded on preprint servers regularly and various public health bodies, nationally and internationally, releasing their respective guidelines.
COVID-19 consultations in primary care are further complicated by contextual factors. In the UK, most of the consultations for patients with COVID-19 related symptoms are conducted remotely.1–3 This usually involves more than one screen being used at the same time, which makes it challenging for GPs to accurately recall and record all relevant clinical features during their consultation with patients with suspected COVID-19 symptoms. When the consultation is in-person in the surgery, personal protective equipment (PPE) restricts normal recording patterns, and this is even worse during home visits.
Good quality epidemiological studies are urgently needed to understand COVID-19.4 Most of the epidemiological studies until now have been conducted in secondary care.5 There is an urgent need for high-quality primary care epidemiological studies for COVID-19. Recently, the use of COVID-19 specific codes have been recommended but these codes mainly cover process measures and diagnostic terms, not clinical presentation features such as symptoms and assessment.6,7 Previous research has suggested that only 37% of clinical problems were coded in primary care records.8 Underreporting of relevant clinical features for COVID-19 in primary care is likely during COVID-19 related consultations, which will be a significant hindrance for high quality primary care research. A computerised, condition-specific template has previously been shown to improve the quality of care and recording in primary care, and it could be implemented for COVID-19.9
The aim of this study was to collate a list of relevant symptoms, assessment items, demographics, and lifestyle and health conditions associated with COVID-19 and its complications, and match these data items with proposed examples of corresponding SNOMED CT clinical terms, which will support the development and implementation of primary care consultation templates. The clinical utility of any template developed based on this work will be to help clinicians record consultations for patients presenting with suspected COVID-19 related symptoms in primary care.
Method
The review of clinical terms involved three distinct stages: 1) search of clinical guidelines, and published and preprint literature to collate the list of relevant clinical data items for COVID-19 consultation; 2) identify examples of corresponding SNOMED CT codes that map to the identified clinical data items; and 3) conceptualise implementation challenges through an NPT lens.
Search for clinical data items for COVID-19
The authors searched PubMed, the preprint server medRxiv, and centre for evidence-based medicine websites for reviews using ’COVID-19‘ as a keyword on 14 May 2020. The PubMed search resulted in 963 articles, while 548 articles were found on preprint server medRxiv. The inclusion criteria were systematic reviews and meta-analyses relating to symptoms, sociodemographic and lifestyle factors, past medical history, and assessment of COVID-19 . As the focus was related to primary care assessment, reviews relating to blood tests and imaging for COVID-19 were excluded. Twenty-one systematic reviews on preprint servers and 24 published systematic reviews from PubMed were identified. The authors searched for COVID-19 related guidelines on Public Health England, Health Protection Scotland, Public Health Wales, British Medical Journal (BMJ), Royal College of General Practitioners (RCGP), National Institute for Health and Care Excellence (NICE), and World Health Organization (WHO) websites. Sixteen clinical guidelines were considered for collating the list of COVID-19 consultation data items described above.
Search for corresponding clinical terms for COVID-19
SNOMED CT is the most comprehensive structured clinical terminology in use around the world and can be used in electronic health records (http://www.snomed.org/snomed-ct/why-snomed-ct). This international clinical terminology has been implemented across various health and care settings, including primary and secondary care. Principles outlined in Data Quality Guidance: Transitioning from Read to SNOMED CT by NHS Digital were used for choosing examples of proposed SNOMED CT clinical terms.10 First, the authors referred to appropriate SNOMED hierarchies, for example, ‘disorders’ or ‘situation’ for recording health conditions, and ‘finding’ or ‘observable entity’ for recording symptoms and signs. Only SNOMED CT codes that had equivalent Read codes were considered, as Read codes are still in use in general practice in Scotland. Codes that were regarded as ‘inactive’ and no longer in use were also excluded. SNOMED CT UK edition (version 20200415) was interrogated by the NHS Digital web browser to search for terms and identifiers for each of the clinical data items identified from the previous step. Additionally, the SNOMED CT code identified was matched to the corresponding Read version 2 codes using NHS Digital browser.11 https://hscic.kahootz.com/connect.ti/t_c_home/viewdatastore?dsid=407588&adv=S&showAllColumns=N&datViewMode=list&showSingleItem=N&cardColNo=
Conceptualising implementation of consultation template
GP consultation templates are often viewed as less patient-centred and potentially disruptive to communication.12 The majority of existing consultation templates are used for management of long-term conditions; however, they have also been used for recording management of acute infections.13 Widespread adaptation of a template in a short timeframe can provide significant implementation challenges. An NPT lens was used to conceptualise these challenges and corresponding key strategies to deal with those challenges.14
Results
Clinical data items and SNOMED CT codes
In total, searches identified 32 symptoms associated with COVID-19 presentation from 10 guidelines,1,3,15–22 13 published reviews,23–35 and 12 preprint reviews.36–47 See Table 1 for the list of symptoms and proposed corresponding SNOMED CT codes. The symptoms of COVID-19 were heterogenous in nature and included flu-like; respiratory; gastrointestinal; central nervous system; ear, nose, and throat; and eye symptoms reported in the literature.
Table 1. Symptoms and assessment items relevant for COVID-19 primary care consultation with respective SNOMED CT concept identifiers.
Symptoms (with respective SNOMED CT concept identifiers) | Primary care assessment (with respective SNOMED CT concept identifiers) |
---|---|
1. Date of onset of symptoms SCTID: 5201910000001032. H/O fever SCTID: 866621000000103 (common)3. C/O cough SCTID: 272039006 (common)4. Productive cough SCTID: 28743005 (common)5. Fatigue-symptom (finding) SCTID: 272060000 (common)6. Myalgia/muscle pain SCTID: 68962001 (common)7. Dyspnoea SCTID: 267036007 (common)8. Has a sore throat SCTID: 162388002 (common)9. C/O anosmia SCTID: 272028008 (common)10. C/O loss of taste sense SCTID: 272041007 (common)11. Bloodstained sputum SCTID 6128100512. Chest pain SCTID: 2985700913. Joint pain SCTID: 5767600214. C/O shivering SCTID: 16185500315. Dizziness SCTID: 40464000316. C/O a headache SCTID: 27202700317. H/O disturbance of consciousness SCTID: 9111100000010818. Convulsion SCTID: 9117500019. Syncope symptom SCTID: 27203000520. Nausea SCTID: 422587007121. C/O vomiting SCTID: 27204400422. Loss of appetite SCTID: 7989000623. Diarrhoea SCTID: 6231500824. Abdominal pain SCTID: 2152200125. Gastrointestinal haemorrhage SCTID: 7447400326. Nasal symptoms SCTID: 24930700327. Rhinorrhoea SCTID: 6453100328. C/O nasal congestion SCTID: 27203400129. Respiratory symptom SCTID: 16192000130. Red eye SCTID: 70363000331. C/O a rash SCTID: 16241500832. Palpitations SCTID: 80313002 | 1. Rockwood Clinical Frailty Scale SCTID: 4454140072. Dyspnoea on exertion SCTID: 608450063. Breathless at rest (finding) SCTID: 1619410074. Ability to perform activities of everyday life SCTID: 2845450015. Unable to climb stairs SCTID: 1652470066. Normal fluid intake SCTID: 1618430097. Not taking fluids (finding) SCTID: 1618450028. Oliguria SCTID: 831280099. Anuria (finding) SCTID: 247200210. Unable to stand (finding) SCTID: 16190300011. C/O cold extremities SCTID: 16199600112. Blue lips (finding) SCTID: 16274300013. Mentally alert SCTID: 24823400814. O/E confused SCTID: 16270200015. O/E disorientated SCTID: 163608000Vital Observations (if available)16. O/E temperature (observable entity) SCTID: 30964600817. O/E pulse rate SCTID: 16298600718. Peripheral oxygen saturation SCTID: 43131400419. O/E blood pressure reading SCTID: 16302000720. O/E respiratory rate SCTID: 162913005 |
C/O= complains of. H/O = history of. O/E = on examination. SCTID = SNOMED CT Identifier
The clinical domain of primary care assessment for COVID-19 had the least number of supporting reviews (two preprint reviews)39,48 and the majority of the data items included were on the basis of clinical guidelines,1–3,16–20,49,50 which in turn were based on expert opinions (Table 1). The data items included for COVID-19 assessment were based on data items validated for general practice consultations, but not specifically for COVID-19 (for example, telephone consultation for suspected sepsis49 and use of the NEWS2 tool1).
Demographic factors (age, sex, and ethnicity) were reported to be relevant for COVID-19 susceptibility and complications by two guidelines,15,20 10 published reviews,5,25,26,28,30,33,51–54 and seven preprint reviews.37,43,55–59 Lifestyle factors (working, smoking, and body mass index) were reported to be relevant for COVID-19 related assessment by two guidelines,15,20 one published review,51 and seven preprint reviews.37,43,55–57,59,60 Individuals working in the health profession were regarded as high risk by one guideline.20 See Table 2 for the list of relevant demographics and lifestyle factors, and examples of corresponding SNOMED CT codes (apart from clinical terms for age and sex, which are usually recorded in all primary care records).
Table 2. Demographic, lifestyle, and existing health conditions relevant for COVID-19 primary care consultations.
Lifestyle and demographics (with respective SNOMED CT concept identifiers) | Past medial history (PMH) relevant for COVID-19 primary care consultation (with respective SNOMED CT concept identifiers) |
---|---|
1. Agea2. Sexa3. Ethnicity/related nationality data (observable entity) SCTID: 1860340074. Health profession SCTID: 2233660095. Current smoker SCTID: 771760026. Ex-smoker SCTID: 85170067. Non-smoker SCTID: 83920008. Finding of body mass index SCTID: 301331008 | 1. High-risk category for developing complication from COVID-19 infection SCTID: 13005610000001072. H/O diabetes mellitus SCTID: 1614450093. H/O hypertension SCTID: 1615010074. Ischaemic heart disease SCTID: 4145450085. H/O heart failure SCTID: 1615050036. Rheumatic heart disease SCTID: 236850007. H/O atrial fibrillation SCTID: 3124420058. Cardiac arrhythmia SCTID: 6982470079. Congenital heart disease SCTID: 1321300910. Pulmonary heart disease SCTID: 27409600011. H/O asthma SCTID: 16152700712. History of chronic obstructive pulmonary disease SCTID: 27047300113. Pulmonary emphysema SCTID: 8743300114. H/O bronchiectasis SCTID: 93943100000010815. Cystic fibrosis SCTID: 19090500816. Pulmonary fibrosis SCTID: 5161500117. Chronic kidney disease SCTID: 70904400418. Chronic liver disease SCTID: 32838300119. H/O stroke SCTID: 27552600620. H/O epilepsy SCTID: 16148000821. H/O dementia SCTID: 16146500222. Multiple sclerosis SCTID: 2470000723. Motor neurone disease SCTID: 3734000024. Patient immunocompromised SCTID: 37038800625. Pregnant SCTID: 77386006 |
aInformation on age and sex is usually documented on all electronic primary care records and is not needed in a consultation template. H/O = history of. SCTID = SNOMED CT Identifier.
In total, 25 health conditions were identified with COVID-19 vulnerability and/or complications, reported by two guidelines,15,20 16 published reviews5,25–28,30–33,54,61–66 and 10 preprint reviews.37,39,42,45,47,57,59,60,67,68 The list of conditions included the ’high-risk‘ or ’extremely vulnerable from COVID-19’ criteria based on guidelines issued by Public Health England and Health Protection Scotland.69,70 The list included a breadth of conditions ranging from cardiovascular, respiratory, immunosuppressed conditions, and previous cancer (see Table 2 for the list of medical conditions and the proposed examples of corresponding SNOMED CT codes). The mapping Read version 2 codes for the SNOMED CT codes identified are listed in Supplementary file Tables S1-4.
Implementation challenges and solutions
There is an extensive literature regarding barriers and facilitators to digital health implementation.71 This literature has demonstrated the importance of considering implementation issues whenever introducing any new digital health system, including those relating to electronic medical record systems.72 While electronic medical record systems are fully integrated within general practice in the UK, changes to functionality or uptake and utilisation of new templates within electronic medical record systems may not become widespread unless potential barriers or facilitators to use are considered.73 NPT is a theory of implementation that has been used extensively over the last decade to understand how new service innovations, particularly digital health innovations, can become embedded and implemented, or not, as part of routine practice.14 It suggests the need to consider issues relating to: coherence, how people make sense of a new way of working; cognitive participation, the engagement work required to get people to ’buy into‘ adopting a new way of working; collective action, the work of operationalising a new digital tool; and reflexive monitoring, the work of appraising, judging, or adapting a new digital innovation. There is evidence that considering and addressing such issues at the start of any new digital intervention will enhance the likelihood of routine embedding as part of normal practice. Table 3 outlines key issues that should be addressed in order to enhance uptake and utilisation of any new COVID-19 template. As a proof of concept, a COVID-19 consultation template prototype using data items relevant for symptoms and assessment was developed at a practice level in EMIS (Figure 1). Such consultation template prototypes may have to be modified after operationalisation, based on user feedback.
Table 3. Key Normalisation Process Theory-informed implementation issues to consider when introducing a new COVID-19 template.
Coherence | Ensuring that potential users are aware of the new template and that they understand the rationale for trying to promote utilisation with every COVID-19 patient. |
Cognitive participation | Engagement with users will be key to ensure they will invest time using the template.Ensuring that the use of the template should assist primary care clinicians in recording relevant clinical items rather than act as a hindrance or source of additional work.Ensuring users are clear that the items included in the template are evidence based and that it is clinically worthwhile to record the data items within the template.Champions within the GP workforce can be valuable to promote uptake. |
Collective action | Any template needs to be easy to navigate and use. A template that is too time-consuming to complete is unlikely to achieve widespread utilisation. Consequently, any template needs to be embedded in the currently used electronic medical record system. |
Reflexive monitoring | Providing feedback to users regarding data collected from the template will enable them to see the potential benefits and learning that can be gained through use of the template. Providing a mechanism to allow iterative feedback so that the template can be improved in line with user comments would also be important. |
Figure 1. A consultation template prototype in EMIS with symptoms and assessment items for recording COVID-19 consultations in primary care.
Discussion
The authors identified 32 symptoms, 20 assessment items, eight demographic and lifestyle features, and 25 health conditions relevant for recording in COVID-19 primary care consultations. The supporting evidence base for these data items comprised of 16 clinical guidelines, 24 published, and 21 unpublished systematic reviews. The authors propose examples of corresponding clinical terms for all clinical data items from the SNOMED CT browser, which can be used to develop consultation templates for different primary care IT system providers. The authors also discuss the likely implementation challenges and potential solutions for large scale roll out of a COVID-19 consultation template. The contents of any COVID-19 consultation template may have to be adapted in future as knowledge and understanding evolves.
Strengths and limitations
This is the first study to collate a list of relevant clinical items and corresponding clinical terms for COVID-19 consultation. The search for preprint servers enabled the authors to include the most up-to-date evidence, with the caveat that these platforms publish rapid non-peer reviewed literature. This study also outlines an implementation blueprint using a well-known theoretical framework for complex interventions.
There are several limitations. First, the authors did not employ a systematic search strategy for the literature review, and did not conduct a quality appraisal of the included studies as these were not the objectives of this study. The study objective was to facilitate standardised data collection, which in turn can lead to high quality research and strengthen the evidence base. Several data items were included from preprint studies that have not undergone the scrutiny of peer review, and future evidence may suggest that recording of these data items is not necessary for risk assessment in primary care.
Comparison with existing literature
Implementation of a COVID-19 consultation template is likely to face similar challenges to those observed with implementation of other general practice consultation templates. The previous positive experiences with the use of a template have included providing a structured consultation and being more comprehensive, while the use of a template has also been perceived as less patient-centred and more focused on a biomedical agenda.12,74,75 The uptake of a template in clinical practice is not likely to be universal; clinicians may need prompting and the template may require reinforcing to improve utilisation.13 There have been very few primary care-based studies of COVID-19, and these studies have not been able to report on symptoms or assessment due to inconsistencies in recording of symptoms in primary care.76,77
Implications for research and practice
The list of clinical terms can lead to the development of COVID-19 consultation templates, which in turn will help with standardised data collection and high quality research. A consultation template can potentially help with quality of clinical care and record keeping by facilitating comprehensive coverage of various clinical domains relevant to COVID-19.78 The use of a consultation template along with coding of other process measures included in the recently published ontology79 https://bioportal.bioontology.org/ontologies/COVID19/?p=summary and SNOMED CT codes on COVID-19 released by NHS Digital80 https://hscic.kahootz.com/connect.ti/COVID19_info_sharing/view?objectId=67227941can also help with disease surveillance. Several data items related to demographics, lifestyle, and past medical history may already be recorded in patient’s existing primary care records. These items are still included in the template as they will be relevant in out-of-hours settings where this information may not be readily available. The authors acknowledge that the codes presented are only examples for recording the relevant clinical data items. In practice, there are often multiple ways of recording a single data item and previous research has suggested evidence of considerable heterogeneity in SNOMED CT coding.81,82 A professional consensus exercise will be needed among clinician users to agree on appropriate SNOMED CT clinical terms. The use of a COVID-19 consultation template has the potential to offer consistency in data collection, albeit with some variations in codes used to record clinical data items.
Funding
There are no funders to report for this article.
SdeL is Director of the Royal College of General Practitioners, Research and Surveillance Centre (English national surveillance system). SdeL has received commercial funding for investigator led research, and belongs to advisory boards, but not related to COVID-19 and all through his university.
Ethical approval
No ethical approval was required.
Provenance
Freely submitted; externally peer reviewed.
Acknowledgements
References
- 1.National Institute for Health and Care Excellence COVID-19 rapid guideline: managing suspected or confirmed pneumonia in adults in the community. NG165. https://www.nice.org.uk/guidance/ng165. 2020 13 Aug 2020. [PubMed]
- 2.Greenhalgh T, Koh GCH, Car J. Covid-19: a remote assessment in primary care. BMJ. 2020;368::m1182. doi: 10.1136/bmj.m1182. [DOI] [PubMed] [Google Scholar]
- 3.Royal College of General Practitioners Guide to triaging patients with potential symptoms. https://elearning.rcgp.org.uk/mod/page/view.php?id=10704. 2020 13 Aug 2020.
- 4.Lipsitch M, Swerdlow DL, Finelli L. Defining the epidemiology of Covid-19 — studies needed. N Engl J Med. 2020;382(13):1194–1196. doi: 10.1056/NEJMp2002125. [DOI] [PubMed] [Google Scholar]
- 5.Wynants L, Van Calster B, Collins GS, et al. Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal. BMJ. 2020;369:m1328. doi: 10.1136/bmj.m1328. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.de Lusignan S, Williams J. To monitor the COVID-19 pandemic we need better quality primary care data. BJGP Open. 2020;4(2):bjgpopen20X101070. doi: 10.3399/bjgpopen20X101070. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Faculty of Clinical Informatics COVID-19 coding in primary care. https://facultyofclinicalinformatics.org.uk/web/content/1607?unique=425692a55f2018b717232f96407b66f158c6d52c&download=true. 2020 13 Aug 2020.
- 8.Salisbury C, Procter S, Stewart K, et al. The content of general practice consultations: cross-sectional study based on video recordings. Br J Gen Pract. 2013;63(616):e751–e759. doi: 10.3399/bjgp13X674431. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Fung CH. Computerized condition-specific templates for improving care of geriatric syndromes in a primary care setting. J Gen Intern Med. 2006;21(9):989–994. doi: 10.1007/BF02743150. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. NHS Digital Data Quality Guidance: transitioning from Read to SNOMED CT. Version 5. https://hscic.kahootz.com/gf2.ti/f/762498/54542725.1/DOCX/-/Data_Quality_Guidance_for_Primary_Care_v2.docx. 2019 13 Aug 2020.
- 11. NHS Digital Read v2 to SNOMED CT mapping lookup (April 2020) https://hscic.kahootz.com/connect.ti/t_c_home/viewdatastore?dsid=407588&adv=S&showAllColumns=N&datViewMode=list&showSingleItem=N&cardColNo= 2020 13 Aug 2020.
- 12.Swinglehurst D, Greenhalgh T, Roberts C. Computer templates in chronic disease management: ethnographic case study in general practice. BMJ Open. 2012;2(6):e001754. doi: 10.1136/bmjopen-2012-001754. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Chen C, Crowley R. Improving assessment of children with suspected respiratory tract infection in general practice. BMJ Open Qual. 2019;8(2):e000450. doi: 10.1136/bmjoq-2018-000450. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.May CR, Cummings A, Girling M, et al. Using Normalization Process Theory in feasibility studies and process evaluations of complex healthcare interventions: a systematic review. Implement Sci. 2018;13(1):80. doi: 10.1186/s13012-018-0758-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.BMJ Best Practice Coronavirus disease 2019 (COVID-19) https://bestpractice.bmj.com/topics/en-gb/3000168. 2020 13 Aug 2020.
- 16.Public Health England COVID-19: investigation and initial clinical management of possible cases. https://www.gov.uk/government/publications/wuhan-novel-coronavirus-initial-investigation-of-possible-cases/investigation-and-initial-clinical-management-of-possible-cases-of-wuhan-novel-coronavirus-wn-cov-infection. 2020 13 Aug 2020.
- 17.Public Health Wales (COVID-19) INTERIM guidance for primary care management of patients presenting to primary care. https://phw.nhs.wales/topics/latest-information-on-novel-coronavirus-covid-19/information-for-healthcare-workers-in-wales/180320-interim-primary-care-guidance-covid19. 2020 13 Aug 2020.
- 18.Razai MS, Doerholt K, Ladhani S, et al. Coronavirus disease 2019 (covid-19): a guide for UK GPs. BMJ. 2020;368::m800. doi: 10.1136/bmj.m800. [DOI] [PubMed] [Google Scholar]
- 19.Scottish Government COVID-19 Scottish primary care hub triage guide. https://www.gov.scot/binaries/content/documents/govscot/publications/advice-and-guidance/2020/04/coronavirus-covid-19-clinical-advice/documents/covid-19-cmo-clinical-advice-primary-care-hub-triage-guide/covid-19-cmo-clinical-advice-primary-care-hub-triage-guide/govscot%3Adocument/COVID-19%2BCMO%2Bclinical%2Bguidance%2B-%2Bappendix%2B1-%2BScottish%2Bprimary%2Bcare%2Bhub%2Btriage%2Bguide%2B-%2B3%2BApril%2B2020.pdf. 2020 18 Aug 2020.
- 20.World Health Organization. International Severe Acute Respiratory and Emerging Infection Consortium Case record form instructions: severe acute respiratory infection clinical characterisation data tools. https://media.tghn.org/medialibrary/2016/06/ISARIC-WHO-SARI_Case_Record_Form_7JAN16.pdf. 2020 13 Aug 2020.
- 21.Healthcare Improvement Scotland Assessment of COVID-19 in primary care. https://www.sign.ac.uk/our-guidelines/assessment-of-covid-19-in-primary-care/ 2020 13 Aug 2020.
- 22.Struyf T, Deeks JJ, Dinnes J, et al. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease. Cochrane Database Syst Rev. 2020;7(7):CD013665. doi: 10.1002/14651858.CD013665. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Ludvigsson JF. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 2020;109(6):1088–1095. doi: 10.1111/apa.15270. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Hu Y, Sun J, Dai Z, et al. Prevalence and severity of corona virus disease 2019 (COVID-19): a systematic review and meta-analysis. J Clin Virol. 2020;127:104371. doi: 10.1016/j.jcv.2020.104371. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Zheng Z, Peng F, Xu B, et al. Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis. J Infect. 2020;81(2):e16–e25. doi: 10.1016/j.jinf.2020.04.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Cao Y, Liu X, Xiong L, Cai K. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis. J Med Virol. 2020;63(3) doi: 10.1002/jmv.25822. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Di Mascio D, Khalil A, Saccone G, et al. Outcome of coronavirus spectrum infections (SARS, MERS, COVID 1 -19) during pregnancy: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2020;2(2):100107. doi: 10.1016/j.ajogmf.2020.100107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Fu L, Wang B, Yuan T, et al. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: a systematic review and meta-analysis. J Infect. 2020;80(6):656–665. doi: 10.1016/j.jinf.2020.03.041. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Cheung KS, Hung IFN, Chan PPY, et al. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong cohort: systematic review and meta-analysis. Gastroenterology. 2020;159(1):81–95. doi: 10.1053/j.gastro.2020.03.065. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Della Gatta AN, Rizzo R, Pilu G, et al. Coronavirus disease 2019 during pregnancy: a systematic review of reported cases. Am J Obstet Gynecol. 2020;223(1):36–41. doi: 10.1016/j.ajog.2020.04.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Castagnoli R, Votto M, Licari A, et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review. JAMA Pediatr. 2020 doi: 10.1001/jamapediatrics.2020.1467. [DOI] [PubMed] [Google Scholar]
- 32.Elshafeey F, Magdi R, Hindi N, et al. A systematic scoping review of COVID-19 during pregnancy and childbirth. Int J Gynaecol Obstet. 2020;150(1):47–52. doi: 10.1002/ijgo.13182. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, et al. Latin American Network of Coronavirus Disease 2019-COVID-19 Research. Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis. Travel Med Infect Dis. 2020;34:101623. doi: 10.1016/j.tmaid.2020.101623. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Lovato A, de Filippis C. Clinical presentation of COVID-19: a systematic review focusing on upper airway symptoms. Ear Nose Throat J. 2020:145561320920762. doi: 10.1177/0145561320920762. [DOI] [PubMed] [Google Scholar]
- 35.Asadi-Pooya AA, Simani L. Central nervous system manifestations of COVID-19: a systematic review. J Neurol Sci. 2020;413:116832. doi: 10.1016/j.jns.2020.116832. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.de Souza TH, Nadal JA, Nogueira RJN, et al. Clinical manifestations of children with COVID-19: a systematic review. Pediatr Pulmonol. 2020;55(8):1892–1899. doi: 10.1002/ppul.24885. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Parohan M, Yaghoubi S, Seraj A, et al. Risk factors for mortality in patients with coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies. medRxiv. 2020; doi: 10.1101/2020.04.09.20056291 doi: 10.1080/13685538.2020.1774748. [DOI] [PubMed] [Google Scholar]
- 38.Michelen M, Jones N, Stavropoulou C. In patients of COVID-19, what are the symptoms and clinical features of mild and moderate cases? https://www.cebm.net/covid-19/in-patients-of-covid-19-what-are-the-symptoms-and-clinical-features-of-mild-and-moderate-case. 2020 13 Aug 2020.
- 39.Burrow MR, Treadwell J, Roberts MN. What clinical features or scoring system, if any, might best predict a benefit from hospital admission for patients with COVID-19? https://www.cebm.net/covid-19/what-clinical-features-or-scoring-system-if-any-might-best-predict-a-benefit-from-hospital-admission-for-patients-with-covid-19. 2020 13 Aug 2020.
- 40.Khan MMA, Khan MN, Mustagir MG, et al. COVID-19 infection during pregnancy: a systematic review to summarize possible symptoms, treatments, and pregnancy outcomes. medRxiv. 2020 [Google Scholar]
- 41.Arabi S, Vaseghi G, Heidari Z, et al. Clinical characteristics of COVID-19 infection in pregnant women: a systematic review and meta-analysis. medRxiv. 2020 [Google Scholar]
- 42.Kahathuduwa CN, Dhanasekara CS, Chin S-H. Case fatality rate in COVID-19: a systematic review and meta-analysis. medRxiv. 2020 [Google Scholar]
- 43.Xu L, Yaqian M, Chen G. Risk factors for severe corona virus disease 2019 (COVID-19) patients : a systematic review and meta analysis. medRxiv. 2020 [Google Scholar]
- 44.Heydari K, Rismantab S, Shamshirian A, et al. Clinical and paraclinical characteristics of COVID-19 patients: a systematic review and meta-analysis. medRxiv. 2020 [Google Scholar]
- 45.Ebrahimi M, Saki A, Rahim F. Laboratory findings, signs and symptoms, clinical outcomes of patients with COVID-19 infection: an updated systematic review and meta-analysis. medRxiv. 2020 [Google Scholar]
- 46.Ji W, Zhang J, Bishnu G, et al. Comparison of severe and non-severe COVID-19 pneumonia: review and meta-analysis. medRxiv. 2020 [Google Scholar]
- 47.Jain V, Yuan J-M. Systematic review and meta-analysis of predictive symptoms and comorbidities for severe COVID-19 infection. medRxiv. 2020 doi: 10.1007/s00038-020-01390-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Greenhalgh T, Treadwell J, Burrow R, et al. NEWS (or NEWS2) score when assessing possible COVID-19 patients in primary care? https://www.cebm.net/covid-19/should-we-use-the-news-or-news2-score-when-assessing-patients-with-possible-covid-19-in-primary-care. 2020 13 Aug 2020.
- 49.UK Sepsis Trust GP/ OOH telephone triage sepsis tool. https://sepsistrust.org/wp-content/uploads/2018/06/OOH-and-GP-telephone-triage-Adult-NICE-Final-3.pdf. 2018 13 Aug 2020.
- 50.Royal College of General Practitioners COVID-19 evidence summary clinical management. https://elearning.rcgp.org.uk/mod/page/view.php?id=10570. 2020 13 Aug 2020.
- 51.Vardavas CI, Nikitara K. COVID-19 and smoking: a systematic review of the evidence. Tob Induc Dis. 2020;18:20. doi: 10.18332/tid/119324. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Park M, Cook AR, Lim JT, et al. A systematic review of COVID-19 epidemiology based on current evidence. J Clin Med. 2020;9(4):967. doi: 10.3390/jcm9040967. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Chang T-H, Wu J-L, Chang L-Y. Clinical characteristics and diagnostic challenges of pediatric COVID-19: a systematic review and meta-analysis. J Formos Med Assoc. 2020;119(5):982–989. doi: 10.1016/j.jfma.2020.04.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Minotti C, Tirelli F, Barbieri E, et al. How is immunosuppressive status affecting children and adults in SARS-CoV-2 infection? A systematic review. J Infect. 2020;81(1):e61–e66. doi: 10.1016/j.jinf.2020.04.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Cohen JF, Korevaar DA, Matczak S, et al. COVID-19-related mortality by age groups in Europe: a meta-analysis. medRxiv. 2020 doi: 10.3389/fmed.2020.560685. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Patanavanich R, Glantz SA. Smoking is associated with COVID-19 progression: a meta-analysis. Nicotine Tob Res. 2020;:ntaa082. doi: 10.1093/ntr/ntaa082. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Matsushita K, Ding N, Kou M, et al. The relationship of COVID-19 severity with cardiovascular disease and its traditional risk factors: a systematic review and meta-analysis. medRxiv. 2020 doi: 10.5334/gh.814. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Nasiri MJ, Haddadi S, Tahvildari A, et al. COVID-19 clinical characteristics, and sex-specific risk of mortality: systematic review and meta-analysis. medRxiv. 2020 doi: 10.3389/fmed.2020.00459. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Zhao X, Zhang B, Li P, et al. Incidence, clinical characteristics and prognostic factor of patients with COVID-19: a systematic review and meta-analysis. medRxiv. 2020 [Google Scholar]
- 60.Alqahtani JS, Oyelade T, Aldhahir AM, et al. Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-analysis. PLoS One. 2020;15(5):e0233147. doi: 10.1371/journal.pone.0233147. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Russell B, Moss C, George G, et al. Associations between immune-suppressive and stimulating drugs and novel COVID-19-a systematic review of current evidence. Ecancermedicalscience. 2020;14:1022. doi: 10.3332/ecancer.2020.1022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Wang B, Li R, Lu Z, Huang Y. Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging. 2020;12(7) doi: 10.18632/aging.103000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Emami A, Javanmardi F, Pirbonyeh N, et al. Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis. Arch Acad Emerg Med. 2020;8(1):e35. [PMC free article] [PubMed] [Google Scholar]
- 64.Zuin M, Rigatelli G, Zuliani G, et al. Arterial hypertension and risk of death in patients with COVID-19 infection: systematic review and meta-analysis. J Infect. 2020;81(1):e84–e86. doi: 10.1016/j.jinf.2020.03.059. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91–95. doi: 10.1016/j.ijid.2020.03.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Huang I, Lim MA, Pranata R. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia — a systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr. 2020;14(4):395–403. doi: 10.1016/j.dsx.2020.04.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Shamshirian A, Heydari K, Alizadeh-Navaei R, et al. Cardiovascular diseases burden in COVID-19: systematic review and meta-analysis. medRxiv. 2020:20062869. doi: 10.1016/j.ajem.2020.10.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Chen Y, Gong X, Wang L, et al. Effects of hypertension, diabetes and coronary heart disease on COVID-19 diseases severity: a systematic review and meta-analysis. medRxiv. 2020 [Google Scholar]
- 69.Public Health England Guidance on shielding and protecting people who are clinically extremely vulnerable from COVID-19. https://www.gov.uk/government/publications/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19. 2020 13 Aug 2020.
- 70.Health Protection Scotland Search criteria for highest risk patients for shielding. https://hpspubsrepo.blob.core.windows.net/hps-website/nss/3008/documents/1_covid-19-search-criteria-highest-risk-patients.pdf. 2020 13 Aug 2020.
- 71.Mair FS, May C, O'Donnell C, et al. Factors that promote or inhibit the implementation of e-health systems: an explanatory systematic review. Bull World Health Organ. 2012;90(5):357–364. doi: 10.2471/BLT.11.099424. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Sheikh A, Cornford T, Barber N, et al. Implementation and adoption of nationwide electronic health records in secondary care in England: final qualitative results from prospective national evaluation in "early adopter" hospitals. BMJ. 2011;343:d6054. doi: 10.1136/bmj.d6054. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Bouamrane M-M, Mair FS. A study of general practitioners' perspectives on electronic medical records systems in NHSScotland. BMC Med Inform Decis Mak. 2013;13:58. doi: 10.1186/1472-6947-13-58. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Kazmi Z. Effects of exam room EHR use on doctor-patient communication: a systematic literature review. Inform Prim Care. 2013;21(1):30–39. doi: 10.14236/jhi.v21i1.37. [DOI] [PubMed] [Google Scholar]
- 75.Mann C, Shaw A, Wye L, et al. A computer template to enhance patient-centredness in multimorbidity reviews: a qualitative evaluation in primary care. Br J Gen Pract. 2018;68(672):e495–e504. doi: 10.3399/bjgp18X696353. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.de Lusignan S, Dorward J, Correa A, et al. Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study. Lancet Infect Dis. 2020 doi: 10.1016/S1473-3099(20)30371-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Williamson E, Walker AJ, Bhaskaran KJ The OpenSAFELY Collaborative. OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients. medRxiv. 2020 [Google Scholar]
- 78.Cahan A, Cimino JJ. A learning health care system using computer-aided diagnosis. J Med Internet Res. 2017;19(3):e54. doi: 10.2196/jmir.6663. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.BioPortal COVID-19 surveillance ontology. https://bioportal.bioontology.org/ontologies/COVID19/?p=summary. 2020 13 Aug 2020.
- 80.NHS Digital COVID-19 SNOMED CT codes by groups 20200401v1.0. https://hscic.kahootz.com/connect.ti/COVID19_info_sharing/view?objectId=67227941. 2020 13 Aug 2020.
- 81.Andrews JE, Patrick TB, Richesson RL, et al. Comparing heterogeneous SNOMED CT coding of clinical research concepts by examining normalized expressions. J Biomed Inform. 2008;41(6):1062–1069. doi: 10.1016/j.jbi.2008.01.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Andrews JE, Richesson RL, Krischer J. Variation of SNOMED CT coding of clinical research concepts among coding experts. J Am Med Inform Assoc. 2007;14(4):497–506. doi: 10.1197/jamia.M2372. [DOI] [PMC free article] [PubMed] [Google Scholar]